Envoy Medical, Inc. (COCH)
NASDAQ: COCH · Real-Time Price · USD
1.300
-0.030 (-2.26%)
At close: Sep 12, 2025, 4:00 PM EDT
1.290
-0.010 (-0.77%)
After-hours: Sep 12, 2025, 4:10 PM EDT
Envoy Medical Stock Forecast
COCH's stock price has decreased by -59.12% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 2 analysts that cover Envoy Medical stock have a consensus rating of "Strong Buy" and an average price target of $9.25, which forecasts a 611.54% increase in the stock price over the next year. The lowest target is $9.00 and the highest is $9.50.
Price Target: $9.25 (+611.54%)
Analyst Consensus: Strong Buy
* Price targets were last updated on May 27, 2025.
Analyst Ratings
The average analyst rating for Envoy Medical stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $9.25 → $9.5 | Strong Buy | Maintains | $9.25 → $9.5 | +630.77% | May 27, 2025 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $9 → $9.25 | Strong Buy | Maintains | $9 → $9.25 | +611.54% | Apr 21, 2025 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $8.75 → $9 | Strong Buy | Maintains | $8.75 → $9 | +592.31% | Dec 6, 2024 |
| Brookline Capital | Brookline Capital | Strong Buy Initiates $9 | Strong Buy | Initiates | $9 | +592.31% | Oct 14, 2024 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $8.5 → $8.75 | Strong Buy | Maintains | $8.5 → $8.75 | +573.08% | Sep 3, 2024 |
Financial Forecast
Revenue This Year
234.60K
from 225.00K
Increased by 4.27%
Revenue Next Year
289.43K
from 234.60K
Increased by 23.37%
EPS This Year
-1.31
from -1.49
EPS Next Year
-1.42
from -1.31
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 |
|---|---|---|
| High | 315,000 | 420,000 |
| Avg | 234,600 | 289,425 |
| Low | 182,280 | 196,000 |
Revenue Growth
| Revenue Growth | 2025 | 2026 |
|---|---|---|
| High | 40.0% | 79.0% |
| Avg | 4.3% | 23.4% |
| Low | -19.0% | -16.5% |
EPS Forecast
| EPS | 2025 | 2026 |
|---|---|---|
| High | -1.27 | -1.24 |
| Avg | -1.31 | -1.42 |
| Low | -1.38 | -1.64 |
EPS Growth
| EPS Growth | 2025 | 2026 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.